Neuralink gets FDA approval for ‘in-human’ trials of its brain-computer interface
The Neuralink device is designed to be surgically implanted and, according to CEO Elon Musk, will eventually be marketed to the general public.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
The Neuralink device is designed to be surgically implanted and, according to CEO Elon Musk, will eventually be marketed to the general public.
Why this matters
This cryptocurrency story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on CointelegraphRelated market context
Federated Hermes Targets $14B Tokenized Fund Market With Prometheum Q1 2027 Launch
Key Takeaways: Federated Hermes and Prometheum are set to launch the first tokenized fund product in Q1 2027. Prometheum will dist...
Circle targets 40 new markets as stablecoin demand surges globally
Circle's expansion into emerging markets could accelerate global blockchain adoption, enhancing financial inclusion and digital ec...
T. Rowe Price Active Crypto ETF gets another free writing prospectus on file with the SEC
T. Rowe Price's active crypto ETF could reshape investor strategies by offering diversified, actively managed exposure to multiple...
Solana Mobile partners with Ledger to expand mobile ecosystem with new device
The partnership could significantly enhance Solana's ecosystem reach, potentially boosting user engagement and influencing SOL's m...
Ledger unveils Atom, an Android security device with Solana Mobile integration
Ledger's Atom could redefine crypto security by integrating AI oversight and Solana, potentially enhancing user trust and market r...
Cboe wins SEC approval to list options on company performance metrics
Cboe's new options could reshape trading by focusing on company KPIs, potentially increasing market efficiency and altering invest...